Affiliation:
1. School of Chemistry, Chemical Engineering & Life Science, Wuhan University of Technology, Wuhan,
China
2. School of Chemistry, Chemical Engineering & Life Science, Wuhan University of Technology, Wuhan, China
Abstract
Abstract:
Brain diseases, including Alzheimer's disease (AD), brain tumors and Parkinson's
disease (PD), pose heavy pressure on the public healthcare system. The main obstacle
to vanquish brain diseases is the blood-brain barrier (BBB), which is a selective barrier
mainly formed by brain endothelial cells. BBB prevents almost all drugs from reaching
the brain, thereby hindering drug delivery. Over the past few decades, considerable
signs of progress have been made in crossing the BBB and treating brain diseases. Gold
nanoparticles (AuNPs) demonstrate the characteristics of adjustable size, unique optical
properties, flexible surface modification, and good biocompatibility, which all contribute
AuNPs as a promising candidate in biomedical fields. This article reviews the structure
and properties of BBB, and discusses main transport routes through the BBB. Besides,
nanoparticles, specially AuNPs applied in brain diseases as main drug delivery platforms,
are systematically summarized, emphasizing several methods to modify AuNPs,
including tuning particle size and surface modification, which are aimed at promoting
BBB penetration or prolonging circulation time of AuNPs. In addition, AuNPs utilized in
brain diseases are introduced in detail from the aspects of brain imaging, AD, brain tumors,
and PD. Prospects and challenges that need to be considered in further investigations
and clinical transformation of AuNPs used in brain diseases are also included, hoping
to bring new insights into the applications of AuNPs in brain diseases.
Funder
National Natural Science Foundation of China
Fundamental Research Funds for the Central Universities
Publisher
Bentham Science Publishers Ltd.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献